Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 29, 2022
Patent Application Number
16651764
Date Filed
September 28, 2018
Patent Citations
Patent Primary Examiner
A TIGIT antibody, an antigen-binding fragment thereof, and a medical use thereof. The present invention relates to a murine antibody, a chimeric antibody, and a humanized antibody comprising a CDR region of the TIGIT antibody, and a pharmaceutical composition comprising the TIGIT antibody and the antigen-binding fragment thereof, and a use thereof as a medicament. In particular, the present invention also relates to a use of a humanized TIGIT antibody for preparing a medicament for the treatment of TIGIT-associated diseases or conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.